Veru SG&A Expense (TTM) Analysis | YCharts

Veru, Inc. (VERU)

2.64 -0.01 (-0.38%) USD | NASDAQ | Sep 04, 16:00

2.65 +0.01 (+0.38%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VERU.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	16.05M
March 31, 2026	17.70M
December 31, 2025	18.80M
September 30, 2025	19.94M
June 30, 2025	23.20M
March 31, 2025	25.69M
December 31, 2024	28.11M
September 30, 2024	31.18M
June 30, 2024	30.16M
March 31, 2024	33.56M
December 31, 2023	38.81M
September 30, 2023	48.06M
June 30, 2023	59.57M
March 31, 2023	59.43M
December 31, 2022	53.99M
September 30, 2022	43.17M
June 30, 2022	30.81M
March 31, 2022	25.60M
December 31, 2021	23.01M
September 30, 2021	20.67M
June 30, 2021	18.21M
March 31, 2021	16.13M
December 31, 2020	15.13M
September 30, 2020	14.50M
June 30, 2020	14.72M

Date	Value
March 31, 2020	14.79M
December 31, 2019	14.81M
September 30, 2019	14.35M
June 30, 2019	14.61M
March 31, 2019	15.09M
December 31, 2018	15.08M
September 30, 2018	14.82M
June 30, 2018	13.46M
March 31, 2018	12.57M
December 31, 2017	11.17M
September 30, 2017	11.67M
June 30, 2017	11.24M
March 31, 2017	10.49M
December 31, 2016	10.85M
September 30, 2016	10.33M
June 30, 2016	11.53M
March 31, 2016	12.33M
December 31, 2015	13.00M
September 30, 2015	12.35M
June 30, 2015	12.36M
March 31, 2015	11.32M
December 31, 2014	9.468M
September 30, 2014	9.198M
June 30, 2014	6.361M
March 31, 2014	6.872M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

ANI Pharmaceuticals, Inc.	324.76M
Corcept Therapeutics, Inc.	556.47M
Johnson & Johnson	25.14B
Eli Lilly & Co.	12.24B
Lexicon Pharmaceuticals, Inc.	35.34M